Risk for Alzheimer’s dementia lower with treated versus untreated HTN
Aug 14, 2024
The all-cause dementia risk was greater for those with treated and untreated hypertension compared with healthy controls.
Vigorous physical activity may preserve cognitive function in high-risk HTN
Jun 24, 2024
High versus low vigorous physical activity was linked to a lower risk of mild cognitive impairment, probable dementia and MCI/probable dementia in a multivariate model.
More news for Friday, May 19
By
Kimberly Bonvissuto
May 19, 2023
Western diet ID’d as risk factor for Alzheimer’s disease … Sense of purpose promotes cognitive resilience into old age … Genetic links seen for HDL cholesterol, systolic BP with Alzheimer’s disease
Modifiable cardiovascular risk factors linked to severity of COVID-19
Jun 16, 2021
Strategies that improve cardiovascular health also may improve outcomes for people following COVID-19.
Meta-analysis shows decrease in dementia risk with hypertension treatment
Nov 02, 2022
Lowering blood pressure with antihypertensive treatment may reduce the risk for incident dementia in older adults with a history of hypertension.
Monoclonal antibody therapy may cut COVID-19 hospitalizations
Aug 31, 2021
Lower hospitalization rates were seen at 14, 21 and 28 days for high-risk patients with mild-to-moderate COVID-19 who received casirivimab-imdevimab.
High blood pressure may protect ‘oldest old’ from dementia: study
By
Lois A. Bowers
Jan 17, 2017
Older adults who develop high blood pressure later in life have a lower risk of dementia after age 90, especially if they develop hypertension at or after age 80, according to the results of a new study.
Hypertension, type 2 diabetes contribute to brain changes in Puerto Rican seniors
Apr 01, 2022
A high prevalence of hypertension and type 2 diabetes was seen among the Puerto Rican cohort; those with both have deteriorating patterns in major white matter tracts.
Where dementia is most prevalent
By
Lois A. Bowers
Feb 03, 2016
A new tool from the federal government provides county- and state-level prevalence data for Alzheimer’s/dementia and 15 other chronic conditions.
COVID-19 vaccine priority populations vary by state, city: reports
By
Kimberly Bonvissuto
Dec 11, 2020
With the Food and Drug Administration’s vaccine advisory board recommending approval of the Pfizer-BioNTech COVID-19 vaccine for emergency use authorization on Thursday, two data analyses outline which...